[{"address1": "500 Collins Street", "address2": "Level 15", "city": "Melbourne", "state": "VIC", "zip": "3000", "country": "Australia", "phone": "61 3 9629 5566", "fax": "61 3 9629 5466", "website": "https://www.paradigmbiopharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC", "age": 66, "title": "Founder, MD & Executive Chairman", "yearBorn": 1959, "fiscalYear": 2025, "totalPay": 727026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Donna L. Skerrett M.D., MS", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 302253, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Abby  Macnish Niven B.Com., B.Sc., C.F.A.", "age": 42, "title": "Company Secretary & CFO", "yearBorn": 1983, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ravi  Krishnan", "title": "Chief Scientific Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Simon  White", "title": "Director of Investor Relations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Imperiale", "title": "Global Head of Drug Safety & MPS", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beverley  Huttmann", "title": "Commercial Head", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mukesh  Ahuja", "title": "Global Clinical Head of OA", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 10, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2245, "open": 0.2245, "dayLow": 0.2245, "dayHigh": 0.2245, "regularMarketPreviousClose": 0.2245, "regularMarketOpen": 0.2245, "regularMarketDayLow": 0.2245, "regularMarketDayHigh": 0.2245, "payoutRatio": 0.0, "beta": 0.242, "volume": 25000, "regularMarketVolume": 25000, "averageVolume": 2008, "averageVolume10days": 2500, "averageDailyVolume10Day": 2500, "bid": 0.2019, "ask": 0.2444, "bidSize": 5000, "askSize": 2500, "marketCap": 97361736, "fiftyTwoWeekLow": 0.1338, "fiftyTwoWeekHigh": 0.3807, "allTimeHigh": 3.0, "allTimeLow": 0.1147, "fiftyDayAverage": 0.23212, "twoHundredDayAverage": 0.23296535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 72410512, "profitMargins": 0.0, "floatShares": 358084908, "sharesOutstanding": 433682549, "heldPercentInsiders": 0.13835, "heldPercentInstitutions": 0.062340003, "impliedSharesOutstanding": 433682549, "bookValue": 0.03734316, "priceToBook": 6.011811, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -18770744, "trailingEps": -0.04, "enterpriseToEbitda": -3.122, "52WeekChange": -0.3585714, "SandP52WeekChange": 0.14272952, "quoteType": "EQUITY", "currentPrice": 0.2245, "recommendationKey": "none", "totalCash": 16818128, "totalCashPerShare": 0.042, "ebitda": -23190202, "totalDebt": 5484, "quickRatio": 7.173, "currentRatio": 7.462, "debtToEquity": 0.026, "returnOnAssets": -0.55108, "returnOnEquity": -0.81658995, "grossProfits": -20591, "freeCashflow": -14289909, "operatingCashflow": -15993215, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 1017.60266, "financialCurrency": "AUD", "symbol": "PBIGF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1770325200, "shortName": "Paradigm Biopharmaceuticals Ltd", "longName": "Paradigm Biopharmaceuticals Limited", "messageBoardId": "finmb_276414891", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "exchange": "PNK", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1557495000000, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.2245, "regularMarketChange": 0.0, "regularMarketDayRange": "0.2245 - 0.2245", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 2008, "fiftyTwoWeekLowChange": 0.0907, "fiftyTwoWeekLowChangePercent": 0.6778774, "fiftyTwoWeekRange": "0.1338 - 0.3807", "fiftyTwoWeekHighChange": -0.15619999, "fiftyTwoWeekHighChangePercent": -0.4102968, "fiftyTwoWeekChangePercent": -35.85714, "earningsTimestampStart": 1753786740, "earningsTimestampEnd": 1754308800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.04, "fiftyDayAverageChange": -0.007620007, "fiftyDayAverageChangePercent": -0.032827877, "twoHundredDayAverageChange": -0.00846535, "twoHundredDayAverageChangePercent": -0.036337376, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Paradigm Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]